A global pharmaceutical company has turned to Kanata-based Kinaxis for help getting its products from the supplier to the customer.
H. Lundbeck A/S, a drug company known for its production of psychiatric and neurological disorder medications, will implement Kinaxis’ supply chain system in order to improve the company’s end-to-end visibility and create a more cohesive product shipping structure.
“We are excited to have earned the trust of Lundbeck to help them manage their supply chain planning,” said Kinaxis CEO John Sicard. “Working together, we will help Lundbeck better monitor, plan and respond to changes across their supply chain, giving them the agility and speed needed to adapt and make changes in time to make a difference.”
(Sponsored)
Local businesses face hiring obstacles due to immigration pullback, flawed screening
In his 39 years of practicing immigration law, Warren Creates (a rare Law Society Certified Specialist) has never seen an environment so challenging for employers looking to hire workers from
How The Ottawa Hospital uses AI tools to boost health outcomes and streamline clinical efficiency
Dr. Douglas Manuel says it all began with the Ottawa Ankle Rules algorithm, a set of clinical guidelines developed in the early 1990s by The Ottawa Hospital’s Dr. Ian Stiell
Kinaxis opened in Ottawa in 1984 and develops software that can connect entire teams to ensure data is in sync and can also monitor critical expiration dates on products – a key selling point for life sciences companies.
The company is scheduled to release its fourth-quarter and full-year earnings after markets close on Feb. 25.
